|Table of Contents|

Treatment of Chinese medicine of warming Yang for diuresis in 43 malignant ascites patients

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2020 03
Page:
465-469
Research Field:
Publishing date:

Info

Title:
Treatment of Chinese medicine of warming Yang for diuresis in 43 malignant ascites patients
Author(s):
Wang Ruojin1; Li Shaodan1; Cui Yixin1; Wang Pu2; Wu Yu3
1.PLA General Hospital，Beijing 100853，China；2.Hygiene Service Center of Zhanlan Community，Beijing 100037，China；3.Xiyuan Hospital,CACMS，Beijing 100091，China.
Keywords:
external use of traditional Chinese medicine; warming Yang for diuresis; malignant ascites
PACS:
R730.59
DOI:
10.3969/j.issn.1672-4992.2020.03.026
Abstract:
Objective：To evaluate the clinical efficacy and safety of Chinese medicine of warming Yang for diuresis in malignant ascites.The summary and analysis of the outcomes would standardize and promote the technology and approach of external application which was effective for malignant ascites and convenient for clinical practice.Methods：In this study，a total of 43 patients with malignant ascites were selected and randomly assigned to two groups.Patients in the control group (n=22) underwent medical treatment，including simple application of diuresis，albumin supplement and intravenous nutritional support.Subjects in the treatment group (n=21) received the external use of warming Yang for diuresis at Shenque acupoint based on medical treatment.The treatment lasted for 14 days.The efficacy of Chinese medicine of warming Yang for diuresis was assessed on the comparisons of symptoms，signs and improvement of life quality before and after treatment in the treatment group and control group.Results：As a result，Chinese medicine of warming Yang for diuresis could significantly reduce the abdominal girth caused by malignant ascites.In addition，it exerted an obvious alleviation of clinical symptoms，including abdominal distention，abdominal pain and dyspnea and could improve KPS score.Conclusion：Chinese medicine of warming Yang for diuresis did exert a positive clinical efficacy on treating malignant ascites，which alleviated the clinical symptoms and signs of patients，increased KPS score and deserved clinical promotion.

References:

［1］Ammouri L，Prommer EE.Palliative treatment of malignant ascites：Profile of catumaxomab［J］.Biologics：Targets & Therapy，2010（4）：103-110.
［2］HUANG Jinchang，TIAN Zhen.New insights on external treatment of TCM tumors［M］.Beijing：China Traditional Chinese Medicine Press，2014：33.［黄金昶，田帧.中医肿瘤外治新悟［M］.北京：中国中医药出版社，2014：33.］
［3］Spleen and Stomach Disease Branch，Chinese Society of Traditional Chinese Medicine.Expert consensus on the criteria for diagnosis and treatment of liver cirrhosis and ascites(Hainan，2011)［J］.Chinese Journal of Integrated Traditional Chinese and Western Medicine，2012，32(12)：1692-1696.［中华中医药学会脾胃病分会.肝硬化腹水中医诊疗规范专家共识意见(2011年，海南)［J］.中国中西医结合杂志，2012，32(12)：1692-1696.］
［4］CHEN Zhendong，SUN Yan，WANG Zhaoyan.Practical diagnosis and therapy of tumor complications［M］.Hefei：Anhui Science and Technology Press，1997：146.［陈振东，孙燕，王肇炎．实用肿瘤并发症诊断治疗学［M］．合肥：安徽科学技术出版社，1997：146.］
［5］XIAO Tao.Diagnostic and therapeutic strategies for malignant ascites［J］.Cancer News，2010，25(07)：14-15.［肖涛.恶性腹腔积液的诊疗策略［J］.肿瘤时讯，2010，25(07)：14-15.］
［6］QI Nan，GAO Jie，ZHAO Hui，et al.Clinical pharmacokinetic study of bevacizumab combined with chemotherapy in the treatment of ovarian cancer with malignant peritoneal effusion［J］.Chinese Journal of Cancer Prevention and Treatment，2018，25(06)：100-101.［祁楠，高洁，赵辉，等.贝伐珠单抗联合化疗治疗卵巢癌合并恶性腹腔积液的药代动力学临床研究［J］.中华肿瘤防治杂志，2018，25(06)：100-101.］
［7］YANG Fang，HUANG Honglin，LUO Pengfei.Observation on the clinical efficacy of low-dose cisplatin intraperitoneal chemotherapy combined with peritoneal puncture and drainage in the treatment of malignant peritoneal effusion［J］.Journal of Clinical Rational Drug Use，2019，12(04)：32-34.［阳芳，黄洪林，罗鹏飞.小剂量顺铂腹腔化疗联合腹腔穿刺引流治疗恶性腹腔积液的临床疗效观察［J］.临床合理用药杂志，2019，12(04)：32-34.］
［8］BAO Yangyi，GU Kangsheng，PANG Dongsheng，et al.Multicenter clinical study of recombinant and modified human tumor necrosis factor in the treatment of malignant peritoneal effusion［J］.Modern Medical and Health，2018，34(01)：15-17.［鲍扬漪，顾康生，庞东生，等.重组改构人肿瘤坏死因子治疗恶性腹腔积液的多中心临床研究［J］.现代医药卫生，2018，34(01)：15-17.］
［9］ZHANG Feifei，JIN Shizhu，LIU Zishuai.New viewpoints on the treatment of malignant ascites［J］.Journal of Gastroenterology and Hepatology，2017，26(04)：476-478.［张菲菲，金世柱，刘自帅.恶性腹水的治疗新观点［J］.胃肠病学和肝病学杂志，2017，26(04)：476-478.］
［10］LI Zheng，LI Kang，WANG Wei.Clinical observation on the treatment of advanced gastric cancer complicated with malignant ascites by water-drinking and chemotherapy of qunquan gansui［J］.Journal of Liaoning University of Traditional Chinese Medicine，2016，18(02)：146-148.［李政，李康，王巍.葶苈甘遂逐水饮联合化疗治疗晚期胃癌合并恶性腹水临床观察［J］.辽宁中医药大学学报，2016，18(02)：146-148.］
［11］XIA Zhengli，XU Youqi.Progress in the treatment of malignant ascites with traditional Chinese medicine［J］.Journal of Traditional Chinese Medicine，2016，31(05)：632-634.［夏正丽，许尤琪.中医药治疗恶性腹水研究进展［J］.中医学报，2016，31(05)：632-634.］
［12］LIU Meng，JIA Liqun.Differentiation and treatment of malignant ascites by TCM external therapy［J］.Journal of TCM External Therapy，2014，23(04)：53-54.［刘猛，贾立群.恶性腹水的中医外治法辨证与施治［J］.中医外治杂志，2014，23(04)：53-54.］
［13］SONG Fengli，KANG Ning，WANG Wenwen，et al.Analysis of TCM treatment of malignant ascites syndrome and medication regularity［J］.Journal of Traditional Chinese Medicine，2018，33(12)：2298-2303.［宋凤丽，康宁，王文雯，等.中医药治疗恶性腹水证候及用药规律分析［J］.中医学报，2018，33(12)：2298-2303.］
［14］Rodney，ZHOU Siyuan，ZHENG Qianhua，et al.Literature analysis of adjuvant moxibustion treatment for malignant ascites in recent 15 years［J］.Asia-Pacific Traditional Medicine，2017，13(12)：76-79.［罗丹妮，周思远，郑倩华，等.近15年艾灸辅助治疗恶性腹腔积液文献分析［J］.亚太传统医药，2017，13(12)：76-79.］
［15］XU Yi.Clinical observation on 125 cases of malignant tumor ascites treated by acupoint external application of traditional chinese medicine［J］.Zhejiang Journal of Traditional Chinese Medicine，2014，49(8)：576.［徐弋.中药穴位外敷治疗恶性肿瘤腹水125例临床观察［J］.浙江中医杂志，2014，49(8)：576.］

Memo

Memo:
北京市科技计划项目（编号：D161100005116002）
Last Update: 1900-01-01